Nova Eye Medical Ltd ELXMF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.19
- Day Range
- $0.10–0.10
- 52-Week Range
- $0.10–0.19
- Bid/Ask
- $0.00 / $0.10
- Market Cap
- $16.69 Mil
- Volume/Avg
- 8,100 / 8,100
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.40
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Nova Eye Medical Ltd is a medical technology company that develops, manufactures and sells a portfolio of proprietary ophthalmic treatment technologies and devices. Used by eye surgeons globally, these technologies include iTrack minimally invasive glaucoma surgery (MIGS), a consumable surgical device that restores the eye's natural outflow pathway to lower pressure inside the eye and to eliminate patient reliance on anti-glaucoma medications for mild-moderate glaucoma. The company's operating segment include AlphaRET and Glaucoma Surgical Devices, it generates maximum revenue from Glaucoma Surgical Devices. Geographically, it derives a majority of revenue from the United States of America.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 301
- Website
- https://www.nova-eye.com
Valuation
|
Metric
|
ELXMF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.27 |
Price/Sales | 1.40 |
Price/Cash Flow | — |
Price/Earnings
ELXMF
Financial Strength
|
Metric
|
ELXMF
|
|---|---|
Quick Ratio | 0.77 |
Current Ratio | 1.47 |
Interest Coverage | −423.65 |
Quick Ratio
ELXMF
Profitability
|
Metric
|
ELXMF
|
|---|---|
Return on Assets (Normalized) | −30.83% |
Return on Equity (Normalized) | −40.41% |
Return on Invested Capital (Normalized) | −38.09% |
Return on Assets
ELXMF
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Qyrtxjjq | Nkwkqwq | $183.1 Bil | |||
| Stryker Corp
SYK
| Gnycpfzxbw | Fdht | $126.3 Bil | |||
| Boston Scientific Corp
BSX
| Jcjyywqs | Dmhrgm | $110.1 Bil | |||
| Medtronic PLC
MDT
| Blhvnprwn | Kkdrqkv | $100.9 Bil | |||
| Edwards Lifesciences Corp
EW
| Myvjfqblbv | Pfhgj | $37.6 Bil | |||
| DexCom Inc
DXCM
| Ydjjdvhhh | Yzbk | $25.6 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Vbqpdgg | Pmkqjm | $24.1 Bil | |||
| Steris PLC
STE
| Xlxdvyjlz | Hjddppt | $23.0 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Vjrxmkjlq | Wqxd | $22.9 Bil | |||
| Align Technology Inc
ALGN
| Ttgbhswf | Mchftsh | $16.6 Bil |